Story

Molina Healthcare Options Market Prices in 11% Post-Earnings Move

ENTHMSVIIDZHZH-TWJAKOHI
Jul 16, 20261 min read
Molina Healthcare Options Market Prices in 11% Post-Earnings Move

Summary

Options traders are anticipating an 11% swing in Molina Healthcare's stock price following its July 23 earnings report, with historical data showing the stock has a record of exceeding such expectations.

Text size
Background

Options traders are bracing for a significant price swing in Molina Healthcare Inc. (MOH) shares, with market data indicating a potential 11% move in either direction following the company's upcoming earnings release on July 23.

Options Market Expectations

Based on options pricing data compiled by Bloomberg, the market has priced in an 11% move for the health insurer's stock. The company is scheduled to report its quarterly financial results after the market closes on Tuesday, July 23.

This figure, known as the implied move or implied volatility, reflects the market's consensus expectation for the magnitude of the stock's reaction to the earnings report and any forward-looking guidance provided by management. It serves as a benchmark for short-term volatility.

Historical Post-Earnings Volatility

Sample IUX Markets – In-articleAd

A review of Molina's last eight earnings announcements shows a history of significant price reactions. The stock's actual post-earnings move has exceeded the implied move in four of the past eight quarters, or 50% of the time.

Several of these moves were substantially larger than what the options market had anticipated. Key instances include:

  • February 5: A 29.6% decline versus an 8.6% implied move.
  • July 2025: A 26.3% drop compared to a 3.8% implied move.
  • April 22: An 18.4% gain, surpassing the 11.5% implied move.

In the other four quarters over the past two years, the stock's movement was more muted and fell within the range projected by options traders. This historical data suggests that while the market is pricing in a notable move, the potential for an even larger surprise exists.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST